A Quarter Of Teen Girls HPV Vaccinated
An estimated one quarter of teenage US girls are vaccinated against human papillomavirus (HPV).
HPV is a sexually transmitted virus occurring showing up as genital warts and herpes. The disease later causes cervical cancer and it should be prevented ahead to avoid later health complications.
Currently Merck & Co's Gardasil is available as a safe and effective HPV vaccine, and GlaxoSmithKline Plc's Cervarix is expected to be approved in 2009. Common adverse side effects associated with the vaccine are fainting and injection pain, headache, nausea and fever. FDA and CDC ensure Gardasil's safety and recommend every single woman to get the vaccine.
Centers for Disease Control and Prevention examined data from 3000 teenage girls to see how seriously American women take HPV vaccination. The analysis found that in 2007 25% of all girls aged from 13 to 17 received at least one shot out of three recommended. There are about 2.5 million girls of this age nationwide and 25% is a good score, but there are still 75% of them who should be vaccinated. CDC also mentions that the study did not consider vaccination rates among other age groups and there may be a lot of older women left behind.
CDC's research also looked at two other vaccines recommended to girls aged from 11 to 12. One of these is meningitis vaccine and Sanofi-Pasteur's MCV4 is the most known version of the vaccine. CDC reported that 32% of teenagers have received the vaccine in 2007. The other recommended vaccination is against tetanus-diphtheria-acellular pertussis, which was found among 30% girls.
The vaccination rates overall are found to be higher in 2007, compared with the rates in 2006. However, CDC mentions that more still needs to be done to make more women understand how important HPV vaccination is to cut cervical cancer risk.